Humanized antibodies that recognize alpha-synuclein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8609820
SERIAL NO

13662261

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application discloses humanized 9E4 antibodies. The antibodies bind to human alpha synuclein and can be used for immunotherapy of Lewy body disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTHENA BIOSCIENCES LIMITEDADELPHI PLAZA UPPER GEORGE STREET DÚN LAOGHAIRE CO DUBLIN A96 T927 IRELAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nijjar, Tarlochan S Orinda, US 69 533
Saldanha, Jose Enfield, GB 27 1126

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 17, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00